![ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/04/IOIBD-logo.png)
ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease
![The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-020-00360-x/MediaObjects/41575_2020_360_Fig1_HTML.png)
The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
![PredictImmune Ltd on Twitter: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for PredictImmune Ltd on Twitter: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for](https://pbs.twimg.com/media/EZGMSJWWsAASsuT.jpg)
PredictImmune Ltd on Twitter: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for
![Frontiers | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF? Frontiers | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?](https://www.frontiersin.org/files/Articles/575231/fmed-07-00517-HTML/image_m/fmed-07-00517-g001.jpg)
Frontiers | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
![Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590257122000244-ga1.jpg)
Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect
![COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/11/front_matter-JCC-Journal-pdf.jpg)
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease
![Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study](https://www.frontiersin.org/files/Articles/851295/fpubh-10-851295-HTML-r1/image_m/fpubh-10-851295-g001.jpg)
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
![From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications - eBioMedicine From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications - eBioMedicine](https://www.thelancet.com/cms/asset/28c85da9-dc0d-4201-aa83-5d249291644f/gr1.jpg)